[Federal Register Volume 80, Number 132 (Friday, July 10, 2015)]
[Notices]
[Pages 39780-39781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-16893]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-0978]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Emerging Infections Program--Revision--(OMB Control No. 0920-0978,
Expires 8/31/2016), National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases. Various parts of the EIP have received
separate Office of Management and Budget (OMB) clearances (Active
Bacterial Core Surveillance [ABCs]--OMB Control Number 0920-0802 and
All Age Influenza Hospitalization Surveillance--OMB Control Number
0920-0852).
In this revision package we wish to seek OMB clearance to add
Healthcare Associated Infections--Community Interface (HAIC): active
population-based surveillance for healthcare associated pathogens and
infections (including Clostridium difficile infection). There are no
other changes included in this revision request; therefore, no changes
are being made to
[[Page 39781]]
the ABC, FoodNet, and Influenza portions of the EIP.
Activities of the EIPs fall into the following general categories:
(1) Active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies.
Activities of the EIPs are designed to: (1) Address issues that the
EIP network is particularly suited to investigate; (2) maintain
sufficient flexibility for emergency response and new problems as they
arise; (3) develop and evaluate public health interventions to inform
public health policy and treatment guidelines; (4) incorporate training
as a key function; and (5) prioritize projects that lead directly to
the prevention of disease. Proposed respondents will include state
health departments who may collaborate with one or more of the
following: academic institutions, local health departments, public
health and clinical laboratories, infection control professionals, and
healthcare providers. Frequency of reporting will be determined as
cases arise.
The addition of HAIC to the EIP increases the total estimated
burden by 10,300 hours to 22, 755 hours. There is no cost to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department............ ABCs Case Report Form...... 10 809 20/60
Invasive Methicillin- 10 609 20/60
resistant Staphylococcus
aureus ABCs Case Report
Form.
ABCs Invasive Pneumococcal 10 22 10/60
Disease in Children Case
Report Form.
ABCs Non-Bacteremic 10 100 10/60
Pneumococcal Disease Case
Report Form.
Neonatal Infection Expanded 10 37 20/60
Tracking Form.
ABCs Legionellosis Case 10 100 20/60
Report Form.
Campylobacter.............. 10 637 20/60
Cryptosporidium............ 10 130 10/60
Cyclospora................. 10 3 10/60
Listeria monocytogenes..... 10 13 20/60
Salmonella................. 10 827 20/60
Shiga toxin producing E. 10 90 20/60
coli.
Shigella................... 10 178 10/60
Vibrio..................... 10 20 10/60
Yersinia................... 10 16 10/60
Hemolytic Uremic Syndrome.. 10 10 1
Influenza Hospitalization 10 400 15/60
Surveillance Project Case
Report Form.
Influenza Hospitalization 10 100 5/60
Surveillance Project
Vaccination Telephone
Survey.
Influenza Hospitalization 10 100 5/60
Surveillance Project
Vaccination Telephone
Survey Consent Form.
EIP site........................... CDI Case Report Form....... 10 1650 20/60
CDI Treatment Form......... 10 1650 10/60
Resistant Gram-Negative 10 500 20/60
Bacilli Case Report Form.
Person in the community infected Screening Form............. 600 1 5/60
with C. difficile (CDI Cases).
Telephone interview........ 500 1 40/60
Total
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-16893 Filed 7-9-15; 8:45 am]
BILLING CODE 4163-18-P